Your browser doesn't support javascript.
loading
NKAIN2 functions as a novel tumor suppressor in prostate cancer.
Mao, Xueying; Luo, Fei; Boyd, Lara K; Zhou, Bowei; Zhang, Yanling; Stankiewicz, Elzbieta; Marzec, Jacek; Vasiljevic, Natasa; Yu, Yongwei; Feng, Ninghan; Xu, Jia; Lorincz, Attila; Jiang, Yong; Chelala, Claude; Ren, Guoping; Berney, Daniel M; Zhao, Shan-Chao; Lu, Yong-Jie.
Afiliación
  • Mao X; Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Luo F; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Boyd LK; Key Laboratory of Proteomics of Guangdong Province and Key Laboratory of Transcriptomics and Proteomics of Human Diseases Supported by The Ministry of Education of China, Southern Medical University, Guangzhou, 510515, China.
  • Zhou B; Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Zhang Y; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Stankiewicz E; Key Laboratory of Proteomics of Guangdong Province and Key Laboratory of Transcriptomics and Proteomics of Human Diseases Supported by The Ministry of Education of China, Southern Medical University, Guangzhou, 510515, China.
  • Marzec J; Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou, 310009, China.
  • Vasiljevic N; Department of Gynecology and Obstetrics, Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, 310009, China.
  • Yu Y; Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Feng N; Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Xu J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Lorincz A; Department of Pathology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, China.
  • Jiang Y; Department of Urology, Wuxi Second People's Hospital, Nanjing Medical University, Wuxi, 214002, China.
  • Chelala C; Key Laboratory of Proteomics of Guangdong Province and Key Laboratory of Transcriptomics and Proteomics of Human Diseases Supported by The Ministry of Education of China, Southern Medical University, Guangzhou, 510515, China.
  • Ren G; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Berney DM; Key Laboratory of Proteomics of Guangdong Province and Key Laboratory of Transcriptomics and Proteomics of Human Diseases Supported by The Ministry of Education of China, Southern Medical University, Guangzhou, 510515, China.
  • Zhao SC; Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
  • Lu YJ; Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou, 310009, China.
Oncotarget ; 7(39): 63793-63803, 2016 Sep 27.
Article en En | MEDLINE | ID: mdl-27588475

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Genes Supresores de Tumor / Proteínas de la Membrana Límite: Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Genes Supresores de Tumor / Proteínas de la Membrana Límite: Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos